Last 12 months
Inside the activity.
6 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 21 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 3 |
| Apr 2026 | 2 | 5 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 20, 2021 Filed Jan 22, 2021 22:34 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 1,052 | $66.49 | $69,952.63 |
DisclosureSEC source: 0000899243-21-002981 · doc4.xml · nonDerivative · entry 4 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,785 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.44 to $66.57 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:34 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 12,840 | $66.11 | $848,885.78 |
DisclosureSEC source: 0000899243-21-002981 · doc4.xml · nonDerivative · entry 3 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125,837 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.43 to $66.40 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:34 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 1,000 | $64.88 | $64,881.50 |
DisclosureSEC source: 0000899243-21-002981 · doc4.xml · nonDerivative · entry 2 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,138,677 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.35 to $65.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:34 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 14,892 | $4.71 | $70,141.32 |
DisclosureSEC source: 0000899243-21-002981 · doc4.xml · nonDerivative · entry 1 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,139,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:32 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 6,282 | $66.14 | $415,514.72 |
DisclosureSEC source: 0000899243-21-002979 · doc4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,640 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.57 to $66.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:32 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 544 | $64.86 | $35,283.08 |
DisclosureSEC source: 0000899243-21-002979 · doc4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,922 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:33 UTC |
Altier ThomasChief Financial Officer
|
SaleCommon Stock | 4,704 | $64.00 | $301,076.23 |
DisclosureSEC source: 0000899243-21-002580 · doc4.xml · nonDerivative · entry 4 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,550 F4 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.57 to $64.505 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:31 UTC |
Weintraub MichaelDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000899243-21-002579 · doc4.xml · derivative · entry 4 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,163 Underlying: Common Stock · 35,000 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:31 UTC |
Weintraub MichaelDirector
|
SaleCommon Stock | 17,218 | $64.06 | $1,102,936.87 |
DisclosureSEC source: 0000899243-21-002579 · doc4.xml · nonDerivative · entry 3 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,484 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.97 to $64.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:31 UTC |
Weintraub MichaelDirector
|
SaleCommon Stock | 17,782 | $63.67 | $1,132,176.38 |
DisclosureSEC source: 0000899243-21-002579 · doc4.xml · nonDerivative · entry 2 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,702 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.97 to $63.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:31 UTC |
Weintraub MichaelDirector
|
Exercise / conversionCommon Stock | 35,000 | $2.03 | $71,050.00 |
DisclosureSEC source: 0000899243-21-002579 · doc4.xml · nonDerivative · entry 1 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:31 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 5,136 | $64.28 | $330,119.48 |
DisclosureSEC source: 0000899243-21-002578 · doc4.xml · nonDerivative · entry 4 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,466 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.2013 to $64.2850 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 59,986 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · derivative · entry 12 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,992 Underlying: Common Stock · 59,986 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 49,214 | $64.07 | $3,153,067.16 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 10 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,785 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.78 to $64.54 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 10,772 | $63.41 | $683,032.05 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 9 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,173,999 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.78 to $63.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 59,986 | $2.03 | $121,771.58 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 8 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,184,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:27 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 300 | $64.30 | $19,290.99 |
DisclosureSEC source: 0000899243-21-002572 · doc4.xml · nonDerivative · entry 5 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,108 F4 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.20 to $64.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:27 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 5,200 | $63.85 | $332,007.52 |
DisclosureSEC source: 0000899243-21-002572 · doc4.xml · nonDerivative · entry 4 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,408 F4 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.20 to $64.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 17, 2021 Filed Jan 21, 2021 01:33 UTC |
Altier ThomasChief Financial Officer
|
Tax withholdingCommon Stock | 780 | $62.96 | $49,108.80 |
DisclosureSEC source: 0000899243-21-002580 · doc4.xml · nonDerivative · entry 3 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,254 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 17, 2021 Filed Jan 21, 2021 01:31 UTC |
Linetsky DavidSVP, Life Sciences
|
Tax withholdingCommon Stock | 277 | $62.96 | $17,439.92 |
DisclosureSEC source: 0000899243-21-002578 · doc4.xml · nonDerivative · entry 3 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,602 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 17, 2021 Filed Jan 21, 2021 01:28 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Tax withholdingCommon Stock | 334 | $62.96 | $21,028.64 |
DisclosureSEC source: 0000899243-21-002574 · doc4.xml · nonDerivative · entry 3 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,634 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 17, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 25,073 | $62.96 | $1,578,596.08 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 7 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,785 F7 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 17, 2021 Filed Jan 21, 2021 01:27 UTC |
Roberts EvanChief Operating Officer
|
Tax withholdingCommon Stock | 872 | $62.96 | $54,901.12 |
DisclosureSEC source: 0000899243-21-002572 · doc4.xml · nonDerivative · entry 3 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,608 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:33 UTC |
Altier ThomasChief Financial Officer
|
Tax withholdingCommon Stock | 2,604 | $62.96 | $163,947.84 |
DisclosureSEC source: 0000899243-21-002580 · doc4.xml · nonDerivative · entry 2 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,034 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:33 UTC |
Altier ThomasChief Financial Officer
|
GrantCommon Stock | 7,147 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-002580 · doc4.xml · nonDerivative · entry 1 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,638 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on January 15, 2022, 20% of the RSUs shall vest on January 15, 2023, 30% of the RSUs shall vest on January 15, 2024 and 40% of the RSUs shall vest on January 15, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:31 UTC |
Linetsky DavidSVP, Life Sciences
|
Tax withholdingCommon Stock | 1,787 | $62.96 | $112,509.52 |
DisclosureSEC source: 0000899243-21-002578 · doc4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,879 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:31 UTC |
Linetsky DavidSVP, Life Sciences
|
GrantCommon Stock | 28,589 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-002578 · doc4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,666 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on January 15, 2022, 20% of the RSUs shall vest on January 15, 2023, 30% of the RSUs shall vest on January 15, 2024 and 40% of the RSUs shall vest on January 15, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:28 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Tax withholdingCommon Stock | 1,005 | $62.96 | $63,274.80 |
DisclosureSEC source: 0000899243-21-002574 · doc4.xml · nonDerivative · entry 2 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,968 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:28 UTC |
VanDuyn Amy BethSVP, Human Resources
|
GrantCommon Stock | 12,706 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-002574 · doc4.xml · nonDerivative · entry 1 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,973 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on January 15, 2022, 20% of the RSUs shall vest on January 15, 2023, 30% of the RSUs shall vest on January 15, 2024 and 40% of the RSUs shall vest on January 15, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 75,122 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · derivative · entry 11 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,978 Underlying: Common Stock · 75,122 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 7,138 | $62.96 | $449,408.48 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 6 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,149,858 F7 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
GrantCommon Stock | 55,590 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 5 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,156,996 F6 · shares: The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on January 15, 2022, 20% of the RSUs shall vest on January 15, 2023, 30% of the RSUs shall vest on January 15, 2024 and 40% of the RSUs shall vest on January 15, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 25,003 | $63.36 | $1,584,080.07 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 4 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101,406 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.79 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 43,905 | $62.70 | $2,752,659.10 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 3 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,126,409 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 6,214 | $61.40 | $381,553.89 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 2 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170,314 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:28 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 75,122 | $2.03 | $152,497.66 |
DisclosureSEC source: 0000899243-21-002573 · doc4.xml · nonDerivative · entry 1 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:26 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
GrantCommon Stock | 19,059 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-002571 · doc4.xml · nonDerivative · entry 1 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,467 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on January 15, 2022, 20% of the RSUs shall vest on January 15, 2023, 30% of the RSUs shall vest on January 15, 2024 and 40% of the RSUs shall vest on January 15, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:27 UTC |
Roberts EvanChief Operating Officer
|
Tax withholdingCommon Stock | 4,496 | $62.96 | $283,068.16 |
DisclosureSEC source: 0000899243-21-002572 · doc4.xml · nonDerivative · entry 2 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,480 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:27 UTC |
Roberts EvanChief Operating Officer
|
GrantCommon Stock | 28,589 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-002572 · doc4.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,976 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on January 15, 2022, 20% of the RSUs shall vest on January 15, 2023, 30% of the RSUs shall vest on January 15, 2024 and 40% of the RSUs shall vest on January 15, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 01:39 UTC |
Roberts EvanChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 575 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0000899243-21-000770 · doc4.xml · derivative · entry 8 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,935 Underlying: Common Stock · 575 shares Expires 2028-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F9 · derivative.exercise_date: 25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 01:39 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 5,193 | $53.94 | $280,084.46 |
DisclosureSEC source: 0000899243-21-000770 · doc4.xml · nonDerivative · entry 7 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,387 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.67 to $54.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 01:39 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 16,275 | $53.26 | $866,882.99 |
DisclosureSEC source: 0000899243-21-000770 · doc4.xml · nonDerivative · entry 6 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,580 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.66 to $53.64 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 01:39 UTC |
Roberts EvanChief Operating Officer
|
Exercise / conversionCommon Stock | 575 | $4.71 | $2,708.25 |
DisclosureSEC source: 0000899243-21-000770 · doc4.xml · nonDerivative · entry 5 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 606,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 01:39 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 1,100 | $54.25 | $59,678.96 |
DisclosureSEC source: 0000899243-21-000770 · doc4.xml · nonDerivative · entry 4 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 606,280 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.22 to $54.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 01:39 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 7,035 | $53.39 | $375,622.57 |
DisclosureSEC source: 0000899243-21-000770 · doc4.xml · nonDerivative · entry 3 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607,380 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.20 to $53.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 01:39 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 42,382 | $52.74 | $2,235,353.83 |
DisclosureSEC source: 0000899243-21-000770 · doc4.xml · nonDerivative · entry 2 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 614,415 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.20 to $53.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 01:39 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 29,728 | $51.84 | $1,540,959.80 |
DisclosureSEC source: 0000899243-21-000770 · doc4.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 656,797 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.20 to $52.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 01:34 UTC |
Smith Mark DouglasDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0000899243-21-000766 · doc4.xml · derivative · entry 5 Smith Mark Douglas · CIK 0001756253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,193 Underlying: Common Stock · 6,000 shares Expires 2028-09-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: 27,306 options vested and became exercisable on September 5, 2019, with 25% of the remainder vesting on September 5, 2019 and 75% of the remainder vesting in thirty-six (36) equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 01:34 UTC |
Smith Mark DouglasDirector
|
SaleCommon Stock | 300 | $54.06 | $16,218.99 |
DisclosureSEC source: 0000899243-21-000766 · doc4.xml · nonDerivative · entry 4 Smith Mark Douglas · CIK 0001756253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,110 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.63 to $54.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: This amount includes Restricted Stock Units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 01:34 UTC |
Smith Mark DouglasDirector
|
SaleCommon Stock | 2,789 | $52.93 | $147,625.12 |
DisclosureSEC source: 0000899243-21-000766 · doc4.xml · nonDerivative · entry 3 Smith Mark Douglas · CIK 0001756253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,410 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.60 to $53.43 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: This amount includes Restricted Stock Units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.